Insights from a Review of Medical Cannabis Clinical Trials

Minn Med. 2015 Jun;98(6):40-2.

Abstract

The Minnesota Legislature passed a law establishing a medical cannabis program in 2014. One of the first tasks of staff in the new Office of Medical Cannabis at the Minnesota Department of Health was to review scientific literature on medical cannabis. The review was limited to studies involving products similar to those allowed in Minnesota. This article explains how the review was conducted and presents three themes that emerged from it.

Publication types

  • Review

MeSH terms

  • Clinical Trials as Topic
  • Dose-Response Relationship, Drug
  • Humans
  • Medical Marijuana / adverse effects*
  • Medical Marijuana / therapeutic use*
  • Minnesota
  • Observational Studies as Topic
  • Precision Medicine
  • Treatment Outcome

Substances

  • Medical Marijuana